artesunic acid has been researched along with Infections, Staphylococcal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, W; Li, D; Qian, Y; Wei, L; Xia, L | 1 |
| Cao, H; Ding, G; Jiang, W; Li, B; Li, J; Pan, X; Zheng, J; Zhou, H | 1 |
| Cao, H; Cen, Y; Jiang, W; Li, B; Li, J; Liu, X; Pan, X; Zheng, J; Zheng, X; Zhou, H | 1 |
3 other study(ies) available for artesunic acid and Infections, Staphylococcal
| Article | Year |
|---|---|
Artesunate inhibits Staphylococcus aureus biofilm formation by reducing alpha-toxin synthesis.
Topics: Animals; Anti-Bacterial Agents; Artesunate; Bacterial Toxins; Biofilms; Gene Expression Regulation, Bacterial; Hemolysin Proteins; Hemolysis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Virulence Factors | 2021 |
Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation.
Topics: Animals; Anti-Bacterial Agents; Artemisinins; Artesunate; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Female; Indicators and Reagents; Inflammation; Macrophages; Male; Mice; NF-kappa B; Nod2 Signaling Adaptor Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sepsis; Staphylococcal Infections; Toll-Like Receptor 2; Tumor Necrosis Factor-alpha | 2010 |
Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacilli
Topics: Adenosine; Ampicillin; Animals; Anti-Bacterial Agents; Antigens, CD; Artemisinins; Artesunate; Bacterial Load; beta-Lactams; Cytokines; Down-Regulation; Drug Synergism; Drug Therapy, Combination; Female; Interleukin-6; Macrophages, Peritoneal; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Nod2 Signaling Adaptor Protein; Oxacillin; Penicillin-Binding Proteins; Sepsis; Staphylococcal Infections; Toll-Like Receptor 2; Tumor Necrosis Factor-alpha | 2011 |